Jim Merryweather has become vice president of business development at NextBio. Most recently, he was vice president of strategic planning and business development at Applied Biosystems. Prior to that, he was executive vice president for sales and marketing and executive vice president of pharmaceutical corporate development at Ciphergen Biosystems. Before that, he held several positions at Incyte. Merryweather holds a PhD in biochemistry from Washington State University and a BS in chemistry from Northern Illinois University.
Robert Hariri has joined the board of directors of WaferGen Biosystems. He is the CEO of Celgene Cellular Therapeutics. He is also a member of the scientific advisory board for the Archon X Prize for Genomics.